Filing Details
- Accession Number:
- 0001179110-18-003312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-02 17:14:40
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-02 17:14:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695686 | J Joseph Manning | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2018-02-28 | 9,520 | $60.55 | 42,682 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-28 | 2,786 | $60.55 | 39,896 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2018-03-01 | 1,430 | $58.98 | 38,466 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.